One-time liquidation risk, Fosun International sheds its burden and moves forward again

Questioning AI · How will Guo Guangchang’s strategic adjustment affect Fosun’s long-term development?

Produced by | Zhongfang.com

Reviewed by | Li Xiaoyan

On March 31, Fosun International held its 2025 annual performance release in Shanghai, with Chairman Guo Guangchang leading the core management team to directly address market concerns. With a performance report that is “more painful but more confident,” the company systematically explained its strategic logic of proactively clearing historical burdens and focusing on core sectors, conveying firm confidence in navigating economic cycles and moving toward high-quality growth. Despite a non-cash loss of 23.4 billion yuan on the books, core industries remain stable, cash flow is abundant, debt structure is optimized, and future impairment pressures are cleared. Fosun is boldly entering a new stage of lighter, healthier, and more sustainable development through “cutting and discarding.”

By 2025, Fosun International will deliver a core operational report of “steady total volume and optimized structure”: total revenue for the year reaching 173.43 billion yuan, adjusted industrial operating profit of 4 billion yuan, with four major subsidiaries contributing 128.2 billion yuan, accounting for 74% of the group’s total revenue, highlighting the continued focus on core businesses. Overseas revenue reached 94.86 billion yuan, increasing its proportion to 54.7%, marking a period of fruitful globalization. Adjusted net asset value stands at 133.5 billion yuan, with a NAV per share of HKD 18.1, maintaining solid asset fundamentals.

Market attention to the 23.4 billion yuan annual book loss is not due to deteriorating operations but results from the group’s prudent approach and Hong Kong accounting standards, proactively recognizing one-time non-cash impairments on real estate and non-core assets. Of these, about 55% relates to real estate impairments, and approximately 45% to goodwill and intangible asset impairments in non-core businesses. This impairment does not affect daily operations or cash flow, representing a “book adjustment and risk clearance” strategic move.

From an industry perspective, recent years have seen a deep adjustment in the real estate market, with some commercial property values under pressure; earlier diversification expansion led to underperforming non-core assets and insufficient growth potential, becoming historical burdens that dragged down group valuation and resource allocation. Fosun’s choice to “repair the roof on a sunny day” during a period of stable fundamentals and secure cash flow is a proactive revaluation of risk assets, fundamentally aimed at divesting inefficient assets and eliminating future uncertainties, freeing up resources for core businesses. As Guo Guangchang stated, this move signifies Fosun entering a new development phase: “Resolutely exit assets with poor profitability and subpar value, and focus resources on high-growth core sectors.”

Behind the impairment recognition is Fosun’s steady operation of its four major sectors: health, wealth, happiness, and intelligent manufacturing, with core industries continuously generating profits and cash flow, providing a solid foundation to weather cycles.

The healthcare sector leads growth, driven by innovation and globalization. Fosun Pharma’s net profit attributable to parent was 3.37B yuan, up 21.69% year-on-year. Revenue from innovative drugs reached 9.89B yuan, a 29.59% increase, accounting for 33.16% of pharmaceutical business. Multiple self-developed products have been approved domestically and internationally; nearly 40 innovative drugs have received approval for clinical trials in China, Europe, and the US. Fosun Hanlin has achieved revenue and profit growth for three consecutive years, with products like Hanshizhuang and Hanchuyou covering over 50 countries worldwide, continuously breaking through global commercialization capabilities. From rare disease medications to anti-tumor ADC drugs, the innovation pipeline is gradually entering a harvest period, strengthening technological barriers for long-term growth.

The wealth and happiness sector remains stable, with global expansion highlighting value. Fosun Portugal’s insurance net profit attributable to parent was 201 million euros, up 15.8%, maintaining a 28.1% market share in Portugal. Its international business expanded into Latin America and Africa, accounting for over 30%, with a S&P A-level credit rating, recognized for asset quality internationally. Domestic Fosun Prudential Life’s net profit was 650 million yuan, a 492% surge; Fosun United Health Insurance’s profits significantly increased, with domestic and international insurance businesses synergizing to become a stable source of cash flow and profit. D&R Reinsurance’s gross premiums grew 25% to $2.2 billion, with diversified global layout showing notable results.

The Happy Travel & Culture sector hit record highs, with accelerated light-asset operations. Club Med’s performance set new records, with improved global operational efficiency. The light-asset model is being rapidly replicated, covering high-end resorts and family consumption markets. Assets like Yuyuan Jewelry, Shede Liquor, and Hainan Mining are steadily upgrading, with consumer sectors leveraging brand and channel advantages to better withstand macroeconomic fluctuations.

Regarding market concerns over debt and financing, Fosun CFO Gong Ping disclosed that the group’s multiple financing channels remain smooth, with ongoing debt structure optimization and steadily declining costs. Since 2025, four long-term bonds have been issued overseas, and multiple 2-year credit bonds issued domestically. The proportion of medium- and long-term debt increased from 48.7% in 2024 to 53.5%, effectively extending debt maturities and reducing short-term repayment pressures.

As of now, the group’s cash and bank balances exceed 61 billion yuan, with unused bank credit lines surpassing 144 billion yuan, ensuring ample liquidity. On March 31, Fosun announced a full repurchase of its $205 million bonds maturing in May 2026, using only internal funds, demonstrating financial strength and debt repayment resolve. International rating agencies maintained Fosun’s outlook as “stable,” and communication with banks and bond investors has been widely recognized, supporting future financing capacity.

Co-Chairman Wang Qunbin explicitly stated that the impairment was prudently recognized based on industry cycles and asset outlooks, “From now on, the company has no further impairment pressure.” This judgment alleviates the greatest market uncertainty and lays a foundation for valuation recovery and operational rebound.

At the release, management disclosed a clear mid-term plan: accelerate the sale of heavy assets and non-core subsidiaries, optimize asset portfolio; reduce interest-bearing liabilities below 60 billion yuan; gradually restore net profit attributable to parent above 10 billion yuan; explore capitalization of non-listed assets to improve transparency and valuation.

Meanwhile, Fosun announced multiple shareholder return measures: a share repurchase plan approved by the board, major shareholders and management initiating increased holdings, and a target dividend payout ratio rising from 20% to 35% in fiscal 2026, with dividends expected to be no less than HKD 1.5 billion, actively rewarding investor trust.

Undeniably, the 23.4 billion yuan book loss and asset disposals reflect a phase of pain in Fosun’s development history, also revealing issues caused by early diversification expansion. The progress of non-core asset disposals and the pace of achieving billion-yuan profit targets still require subsequent operational data validation. But in the long run, this “proactive clearing” is a crucial decision for the company to navigate cycles—divesting inefficient assets, focusing on core sectors, and optimizing financial structure are far more valuable than blind expansion during economic fluctuations.

Guo Guangchang emphasized at the release: “Fosun has the ability to cross cycles. There will be pain in the short term, but in the long run, everything we do is to make Fosun more stable and further.” Historically, every deep adjustment has been a new starting point for growth. With its profitable core assets in pharmaceuticals, global insurance, and quality travel & culture, combined with liquidity safety, debt optimization, and impairment clearance, Fosun is gradually shedding its historical burdens and moving onto a high-quality development track of “light assets, high profits, strong innovation, and deep globalization.”

Standing at a new starting point, Fosun’s “streamlining and focusing on core” strategy has entered an implementation phase. As growth momentum from core sectors continues, asset structure improves, and shareholder return mechanisms are refined, this cyclical industry group is expected to see valuation recovery and value redefinition after risk clearance, with a lighter footprint and a new chapter of steady, resilient growth.